SINGLE-USE Bioreactors
Single-Use Bioreactors are disposable cell culture systems designed for biopharmaceutical manufacturing, replacing traditional stainless-steel vessels with pre-sterilized plastic components. These scalable bioprocessing platforms improve operational flexibility, reduce contamination risk, lower cleaning requirements, and accelerate production timelines for vaccines, biologics, gene therapies, and advanced life sciences research and development applications.


Discovery unlocks potential, and translational research turns potential into life-changing therapies. Erick Morris knows this intersection well. As Senior Director at Bristol Myers Squibb, Morris leads translational oncology and cancer immunology programs, bridging scientific insights with clinical breakthroughs.
